BlackRock Health Sciences Opps R (BHSRX)
* As of 28-Feb-14
Quotes delayed, except where indicated otherwise. Currency in USD.
- No Headlines available for BHSRX at this time.
|Morningstar Overall Rating:|
|Annual Report Expense Ratio (net):||1.55%|
Performance & Risk
|5y Avg Return:||24.13%|
|Rank in Category (ytd):||62|
|% Rank in Category (ytd):||47.33%|
|Morningstar Risk Rating:||1|
The investment seeks to provide long-term growth of capital.
The fund invests at least 80% of total assets in equity securities, primarily common stock, of companies in health science and related industries. The health sciences sector can include companies in health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals. It concentrates its investments (i.e., invest more than 25% of its assets) in health sciences or related industries, and may invest in companies located in non-U.S. countries. The fund is non-diversified. View More